FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979734870> ?p ?o ?g. }

• W2979734870 abstract "Abstract Abstract 3505 Paroxysmal nocturnal hemoglobinuria (PNH) is a non-malignant clonal disorder of hematopoietic stem cells characterized by erythrocyte susceptibility to complement-mediated lysis. Untreated, patients with PNH have a reduced life expectancy compared with age-matched controls. The development of cytopenias with infections related to neutropenia, bleeding associated with thrombocytopenia, and vascular thrombosis all contribute to morbidity and mortality. We previously reported that engrafting donor T-cells mediating graft-vs-host hematopoietic effects can eradicate PNH following reduced intensity (RIC) allogeneic hematopoietic cell transplantation (HCT). Here we present long term follow up data on 16 patients with severe PNH who received a RIC peripheral blood HCT at the NHLBI from May 1999 through January 2007. Eligibility for transplantation included a diagnosis of PNH associated with one or more of the following: 1) Transfusion dependence 2) Prior thrombotic episodes 3) Recurrent debilitating hemolytic crisis. Marrow failure, personal preference or unavailability of the drug precluded the use of eculizumab in all patients. Patients received a T-cell replete G-CSF mobilized blood stem cell transplant from an HLA-matched related donor following conditioning with cyclophosphamide (120mg/kg) and fludarabine (125mg/m2). Patients with a significant transfusion history had equine ATG (40mg/kg/day × 4) added to the conditioning regimen (n= 14). The median CD34+ cell dose was 6.9 × 106cells/kg (range 3.1 to 21.1 × 106) and the median CD3+ cell dose was 2.5 × 108cells/kg (range 1.4 to 4.3 × 108). CSA given alone (n=1) or in combination with either MMF (n=4) or mini-dose methotrexate (n=11) was used as GVHD prophylaxis. FACS analysis on blood samples was performed on all patients at baseline and at multiples time-points post-transplant to measure the percentage of GPI negative PNH-type neutrophils (CD15+/CD66b-/CD16-); the median % of GPI-anchored-protein negative neutrophils pre-transplant was 80.1% (range 5.5%-99%). Half of the patients (n=8) were HLA alloimmunized prior to transplantation with a median 76.5% PRA (range 45%-100%). Neutrophil and platelet recovery occurred at a median 14 days (range 9 to 18) and 12 days (range 5 to 15), respectively. Chimerism assessed in T-cell (CD3) and myeloid (CD14,15) lineages by PCR of short tandem repeats (STR) revealed sustained donor engraftment occurred in both myeloid and T-cell lineages in all patients; the median time to achievement of full donor (>= 95%) myeloid and T-cell chimerism was 15 and 30 days respectively. FACS analysis on blood samples collected sequentially after transplant revealed evidence for donor immune-mediated eradication of PNH; although GPI-anchored-protein negative neutrophils were detectable early after transplant, over time these populations declined in size and eventually disappeared in all patients at a median 100 days (range 30 to 150) post transplant. Two patients died, one from complications related to acute GVHD (day 169) and one from complications related to a peptic ulcer disease (2.8 years). The cumulative incidence of grade 2–4 acute GVHD was 50% (n=8) and the cumulative incidence of chronic GVHD was 68.8% (n=10). With a median follow-up of nearly 6 years (range 2.6–11 years), 14 patients (87.1%) survive without any evidence of PNH, transfusion independent and off all anticoagulation. Conclusion: Graft-vs-PNH effects that occur after RIC allogeneic HCT result in durable remission and can achieve excellent long-term survival in patients with debilitating PNH. Allogeneic HCT using RIC should be considered a viable treatment option for PNH patients who have failed or are not candidates for eculizumab treatment. Disclosures: No relevant conflicts of interest to declare." @default.
• W2979734870 created "2019-10-18" @default.
• W2979734870 creator A5004913924 @default.
• W2979734870 creator A5008093274 @default.
• W2979734870 creator A5012614494 @default.
• W2979734870 creator A5024996698 @default.
• W2979734870 creator A5029831997 @default.
• W2979734870 creator A5051959420 @default.
• W2979734870 creator A5071703277 @default.
• W2979734870 creator A5072063614 @default.
• W2979734870 creator A5072164039 @default.
• W2979734870 creator A5076074380 @default.
• W2979734870 creator A5077082272 @default.
• W2979734870 date "2010-11-19" @default.
• W2979734870 modified "2023-09-28" @default.
• W2979734870 title "Long-Term Follow-up of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Severe Paroxysmal Nocturnal Hemoglobinuria" @default.
• W2979734870 doi "https://doi.org/10.1182/blood.v116.21.3505.3505" @default.
• W2979734870 hasPublicationYear "2010" @default.
• W2979734870 type Work @default.
• W2979734870 sameAs 2979734870 @default.
• W2979734870 citedByCount "0" @default.
• W2979734870 crossrefType "journal-article" @default.
• W2979734870 hasAuthorship W2979734870A5004913924 @default.
• W2979734870 hasAuthorship W2979734870A5008093274 @default.
• W2979734870 hasAuthorship W2979734870A5012614494 @default.
• W2979734870 hasAuthorship W2979734870A5024996698 @default.
• W2979734870 hasAuthorship W2979734870A5029831997 @default.
• W2979734870 hasAuthorship W2979734870A5051959420 @default.
• W2979734870 hasAuthorship W2979734870A5071703277 @default.
• W2979734870 hasAuthorship W2979734870A5072063614 @default.
• W2979734870 hasAuthorship W2979734870A5072164039 @default.
• W2979734870 hasAuthorship W2979734870A5076074380 @default.
• W2979734870 hasAuthorship W2979734870A5077082272 @default.
• W2979734870 hasConcept C111684460 @default.
• W2979734870 hasConcept C126322002 @default.
• W2979734870 hasConcept C203014093 @default.
• W2979734870 hasConcept C2776694085 @default.
• W2979734870 hasConcept C2776755627 @default.
• W2979734870 hasConcept C2777063308 @default.
• W2979734870 hasConcept C2777346216 @default.
• W2979734870 hasConcept C2777408962 @default.
• W2979734870 hasConcept C2777991916 @default.
• W2979734870 hasConcept C2779263901 @default.
• W2979734870 hasConcept C2780007613 @default.
• W2979734870 hasConcept C2781440808 @default.
• W2979734870 hasConcept C2911091166 @default.
• W2979734870 hasConcept C71924100 @default.
• W2979734870 hasConcept C8891405 @default.
• W2979734870 hasConcept C90924648 @default.
• W2979734870 hasConceptScore W2979734870C111684460 @default.
• W2979734870 hasConceptScore W2979734870C126322002 @default.
• W2979734870 hasConceptScore W2979734870C203014093 @default.
• W2979734870 hasConceptScore W2979734870C2776694085 @default.
• W2979734870 hasConceptScore W2979734870C2776755627 @default.
• W2979734870 hasConceptScore W2979734870C2777063308 @default.
• W2979734870 hasConceptScore W2979734870C2777346216 @default.
• W2979734870 hasConceptScore W2979734870C2777408962 @default.
• W2979734870 hasConceptScore W2979734870C2777991916 @default.
• W2979734870 hasConceptScore W2979734870C2779263901 @default.
• W2979734870 hasConceptScore W2979734870C2780007613 @default.
• W2979734870 hasConceptScore W2979734870C2781440808 @default.
• W2979734870 hasConceptScore W2979734870C2911091166 @default.
• W2979734870 hasConceptScore W2979734870C71924100 @default.
• W2979734870 hasConceptScore W2979734870C8891405 @default.
• W2979734870 hasConceptScore W2979734870C90924648 @default.
• W2979734870 hasLocation W29797348701 @default.
• W2979734870 hasOpenAccess W2979734870 @default.
• W2979734870 hasPrimaryLocation W29797348701 @default.
• W2979734870 hasRelatedWork W1195512831 @default.
• W2979734870 hasRelatedWork W2167584739 @default.
• W2979734870 hasRelatedWork W2398646277 @default.
• W2979734870 hasRelatedWork W2537106166 @default.
• W2979734870 hasRelatedWork W2549500579 @default.
• W2979734870 hasRelatedWork W2550502648 @default.
• W2979734870 hasRelatedWork W2554027963 @default.
• W2979734870 hasRelatedWork W2556081269 @default.
• W2979734870 hasRelatedWork W2556704178 @default.
• W2979734870 hasRelatedWork W2563940771 @default.
• W2979734870 hasRelatedWork W2580535470 @default.
• W2979734870 hasRelatedWork W2587996964 @default.
• W2979734870 hasRelatedWork W2588899623 @default.
• W2979734870 hasRelatedWork W2591936344 @default.
• W2979734870 hasRelatedWork W2599243698 @default.
• W2979734870 hasRelatedWork W2897656902 @default.
• W2979734870 hasRelatedWork W2911771633 @default.
• W2979734870 hasRelatedWork W2953775728 @default.
• W2979734870 hasRelatedWork W2979493185 @default.
• W2979734870 hasRelatedWork W2980187995 @default.
• W2979734870 isParatext "false" @default.
• W2979734870 isRetracted "false" @default.
• W2979734870 magId "2979734870" @default.
• W2979734870 workType "article" @default.